Novo Nordisk (NVO) stock and Eli Lilly (LLY) stock are in focus as the FDA seeks to remove suicide-risk warnings related to their GLP-1 weight-loss drugs. Read more here.
Audacy on MSN
FDA upgrades shredded cheese recall to Class 1, meaning product poses risk of serious illness or death
The Food and Drug Administration has upgraded a nationwide cheese recall that includes products sold at major Texas retailers ...
The U.S. health regulator asked drugmakers on Tuesday to remove warnings about a potential risk of suicidal thoughts from ...
A large quantity of class A drugs were found during a search of the car, and the driver was arrested for possession with ...
International pharmaceutical leaders and investors gathered in San Francisco on Sunday to explore partnership opportunities ...
Akeso, Inc. (9926.HK) announced the presentation of a real-world study at the 2026 American Society of Clinical Oncology ...
FDA accelerated path and Risto-cel 2026 catalysts, strong cash runway to 2029—read now. Click for more on BEAM.
The Rays have run the gamut with their first overall Draft picks over the years, selecting everyone from franchise players ...
In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...
The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...
Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...
Cheese sold in 20 states, including Massachusetts, is being recalled for Listeria concerns. Here's the full list of affected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback